Top Markets
#1 Black Phoenix Black Phoenix +367.14%
#2 Islamic Coin Islamic Coin +158.30%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +55.03%
#5 Akedo Akedo +53.15%
#6 Acurast Acurast +38.47%
#7 BasedHype BasedHype +30.07%
#8 Cryptopia Cryptopia +22.42%
#9 Playnance Playnance +19.71%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.34%
Coin of the day
Black Phoenix Black Phoenix
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
GENinCode plc GENinCode plc

GENinCode plc

GENI
Classificação em ações #41227
GENinCode Plc specializes in the creation and commercialization of advanced... GENinCode Plc specializes in the creation and commercialization of advanced genetic tests designed to forecast potential health risks based on an individual's DNA. Operating in both the United Kingdom and internationally, their predictive technology empowers individuals and medical professionals alike with proactive health management and targeted intervention strategies. The company's sophisticated molecular diagnostics leverage a combination of clinical algorithms and artificial intelligence to deliver precise patient risk assessments, thereby anticipating the onset of various diseases. Among their specialized tests are: Cardio inCode: A patented genetic assay designed to guide individuals in cardiovascular prevention. Lipid inCode: A genetic diagnostic tool that analyzes seven specific genes associated with familial hypercholesterolemia. SUDD inCode: A genetic test to identify the underlying causes of sudden cardiac death and inherited heart conditions. Thrombo inCode: This test assesses 12 genetic variants linked to hereditary thrombophilia and the general risk of thrombosis (blood clots). Thrombo inCode Reproductive Health: Offering crucial insights into thrombophilia risks particularly relevant to prospective pregnancies. Established in 2018, GENinCode Plc maintains its headquarters in Oxford, United Kingdom.
Preço da ação
$0.01156596
Valor de mercado
$32.34K
Variação (1 dia)
-5.56%
Variação (1 ano)
-43.21%
País
GB
Negociar GENinCode plc (GENI)

Categoria

Healthcare
Rácio P/B de GENinCode plc (GENI)
Rácio P/B em 2026 TTM: 0
De acordo com os relatórios financeiros mais recentes e o preço das ações da GENinCode plc, o rácio P/B atual (TTM) é 0. No final de 2026, o rácio P/B era 0.
Histórico do rácio P/B da GENinCode plc de 2026 a 2026
Rácio P/B no final de cada ano
Ano Rácio P/B Alterar
Não há dados suficientes para as datas fornecidas.
Rácio P/B de empresas semelhantes ou concorrentes
Empresa Rácio P/B Diferença do rácio P/B País
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 4.0441 -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 2.6166 -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 28.7765 -
US
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 21.3575 -
US